Monoclonal Antibodies Market for Colorectal Cancer to Witness Moderate Growth PR Carbon (press release) FOR IMMEDIATE RELEASE, San Francisco – United States – December 11, 2013 (PR Carbon): The market value for monoclonal antibodies (mAbs) in colorectal cancer treatment will experience a moderate increase from $3.7 billion in 2012 to $5.2 billion by ... |
